Amplimmune, Inc.

Amplimmune, Inc.

Amplimmune, Inc.

Overview
Date Founded

2006

Headquarters

45 West Watkins Mill Road,Gaithersburg, MD 20878

Type of Company

Private

Employees (Worldwide)

1,001 - 5,000

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD.

Contact Data
Trying to get in touch with decision makers at Amplimmune, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Senior Director-Clinical Operations

Manager

Scientist

Scientist

Board of Directors

Co-Founder, President & Chief Executive Officer at NextCure, Inc.

Director at ProteinSimple

Paths to Amplimmune, Inc.
Potential Connections via
Relationship Science
You
Amplimmune, Inc.
Recent Transactions
Details Hidden

AstraZeneca Plc, MedImmune LLC purchase Amplimmune, Inc. from InterWest Partners, LLC

Transaction Advisors
Legal Advisor

Advised onMedImmune LLC, AstraZeneca Plc purchase Amplimmune, Inc. from InterWest Partners, LLC

Investors
Details Hidden

Associate Director at Johns Hopkins University - Bloomberg-Kimmel Institute for Cancer Immunotherapy at Sidney Kimmel Comprehensive Cancer Center

Details Hidden

Founder at NextCure, Inc.

Details Hidden

Professor at Johns Hopkins University

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Amplimmune, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Amplimmune, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Amplimmune, Inc..